TB Online is no longer maintained. This is an archive of the site. For news on TB please go to: https://globaltbcab.org/
Moxifloxacin not superior to ethambutol for recurrent TB
Infectious Disease Advisor
March 29, 2019, 11:31 p.m.
Despite reducing the median time to culture conversion, replacing ethambutol with moxifloxacin has not shown efficacy in recurrent tuberculosis treatment success in an 8-week trial, according to a study published in Clinical Infectious Diseases.